This page lists the SEC filings reported by RHO VENTURES IV QP LP.
Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2018-02-08 | RHO VENTURES IV QP LP | ROCKET PHARMACEUTICALS, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2017-02-02 | RHO VENTURES IV QP LP | IntraLinks Holdings, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2016-02-12 | RHO VENTURES IV QP LP | IntraLinks Holdings, Inc. | 6,290,503 | 10.8% | EDGAR |
SC 13G | 2016-02-12 | RHO VENTURES IV QP LP | INOTEK PHARMACEUTICALS CORP | 2,627,790 | 9.9% | EDGAR |
SC 13G/A | 2015-01-30 | RHO VENTURES IV QP LP | IntraLinks Holdings, Inc. | 6,490,503 | 11.4% | EDGAR |
SC 13D/A | 2014-02-14 | RHO VENTURES IV QP LP | Anacor Pharmaceuticals, Inc. | 1,567,892 | 3.8% | EDGAR |
SC 13G/A | 2014-02-11 | RHO VENTURES IV QP LP | IntraLinks Holdings, Inc. | 7,584,296 | 13.6% | EDGAR |
SC 13D/A | 2014-02-05 | RHO VENTURES IV QP LP | Anacor Pharmaceuticals, Inc. | 1,567,892 | 3.8% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.